Published Date: 31 Jan 2024
Research published online in the British Journal of Sports Medicine indicates that a 3 percent or greater annual increase in cardiorespiratory fitness is associated with a 35 percent lower risk of developing prostate cancer, though not dying from it.
Read Full NewsCancer patients aren't just battling a deadly disease—part of their time and energy can also be spent fighting the system intended to cure them, a new study says. The findings are published in the journal JCO Oncology Practice.
October is Breast Cancer Awareness Month, and cancer awareness starts with general breast awareness. Dr. Julie Nangia, medical director of breast oncology at the Dan L Duncan Comprehensive Cancer Center, recommends monthly ...
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has found a novel imaging solution, ...
Loneliness and social isolation are linked to a heightened risk of death from cancer as well as from all causes among those with the disease, finds a pooled data analysis of the available research published online in the ...
1.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
2.
Discovery of estrogen receptor 'switches' may aid breast cancer treatment
3.
Lower screening age calls for more tailored bowel cancer surveillance
4.
Higher Risk of Kidney Cancer Recurrence After Ablative Therapy
5.
Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.
1.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
2.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
3.
How Prevident is Revolutionizing Oral Care
4.
Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology
5.
Understanding the Importance of CA125: A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation